Silenseed Ltd. — Form D
Silenseed Ltd. of JERUSALEM, L3, a company, filed a Form D exempt-offering notice with the SEC on 2014-04-08. The offering totals $500K, of which $500K was reported sold. Industry: Biotechnology.
Offering
- Filed: 2014-04-08
- Form: D
- Accession: 0001178913-14-001228
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $500K
- Amount sold: $500K
- Investors: 4
- Date of first sale: 2014-03-25
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-215152
Issuer
- Name: Silenseed Ltd.
- CIK: 0001602634
- Entity type: Corporation
- Jurisdiction: ISRAEL
- Address: GOLDYNE SAVAD INSTITUTE OF GENE THERAPY, JERUSALEM, L3, 9112001
- Phone: 972 2 6743430
Officers, directors & promoters (5)
| Name | Role | Location |
|---|
| Shmuel Cabilly | Director | Tel Aviv, L3 |
| Eithan Galun | Director | Jerusalem, L3 |
| Amotz Shemi | Director | Jerusalem, L3 |
| Ilan Shiloah | Director | Jerusalem, L3 |
| Amotz Shemi | Executive Officer | Jerusalem, L3 |
More